IKT
Inhibikase Therapeutics Inc
Price:  
2.01 
USD
Volume:  
156,955
United States | Biotechnology

IKT Net Margin

As of 2025-07-09, the Net Margin of Inhibikase Therapeutics Inc (IKT) is -7304.7%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

IKT Net Margin - Historical Value
DateValue
2024-12-31 -7304.7%
2023-12-31 -7304.8%
2022-12-31 -15041.7%
2021-12-31 -477.1%
2020-12-31 -407.1%
2019-12-31 -510.7%
2018-12-31 -53.2%
2017-12-31 -21.4%
2016-12-31 -64.9%
-
IKT Net Margin - Peers Comparison